LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Ihre letzten Suchen

  1. AU="Zhao, Andong"
  2. AU="Zhao, Tianshi"
  3. AU="Morris, Helen"

Suchergebnis

Treffer 1 - 10 von insgesamt 51

Suchoptionen

  1. Buch ; Online ; E-Book: Cellular dedifferentiation and regenerative medicine

    Fu, Xiaobing / Zhao, Andong / Hu, Tian

    2018  

    Verfasserangabe Xiaobing Fu, Andong Zhao, Tian Hu
    Schlagwörter Medicine ; Dermatology ; Traumatology ; Regenerative medicine ; Tissue engineering
    Thema/Rubrik (Code) 617.1
    Sprache Englisch
    Umfang 1 Online-Ressource (xii, 291 Seiten), Illustrationen
    Verlag Springer
    Erscheinungsort Berlin
    Erscheinungsland Deutschland
    Dokumenttyp Buch ; Online ; E-Book
    Bemerkung Zugriff für angemeldete ZB MED-Nutzerinnen und -Nutzer
    HBZ-ID HT019628559
    ISBN 978-3-662-56179-9 ; 9783662561775 ; 3-662-56179-4 ; 3662561778
    DOI 10.1007/978-3-662-56179-9
    Datenquelle ZB MED Katalog Medizin, Gesundheit, Ernährung, Umwelt, Agrar

    Kategorien

  2. Artikel ; Online: Mesenchymal stem cell therapy for acute respiratory distress syndrome: from basic to clinics.

    Qin, Hua / Zhao, Andong

    Protein & cell

    2020  Band 11, Heft 10, Seite(n) 707–722

    Abstract: The 2019 novel coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has occurred in China and around the world. SARS-CoV-2-infected patients with severe pneumonia rapidly develop acute respiratory ... ...

    Abstract The 2019 novel coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has occurred in China and around the world. SARS-CoV-2-infected patients with severe pneumonia rapidly develop acute respiratory distress syndrome (ARDS) and die of multiple organ failure. Despite advances in supportive care approaches, ARDS is still associated with high mortality and morbidity. Mesenchymal stem cell (MSC)-based therapy may be an potential alternative strategy for treating ARDS by targeting the various pathophysiological events of ARDS. By releasing a variety of paracrine factors and extracellular vesicles, MSC can exert anti-inflammatory, anti-apoptotic, anti-microbial, and pro-angiogenic effects, promote bacterial and alveolar fluid clearance, disrupt the pulmonary endothelial and epithelial cell damage, eventually avoiding the lung and distal organ injuries to rescue patients with ARDS. An increasing number of experimental animal studies and early clinical studies verify the safety and efficacy of MSC therapy in ARDS. Since low cell engraftment and survival in lung limit MSC therapeutic potentials, several strategies have been developed to enhance their engraftment in the lung and their intrinsic, therapeutic properties. Here, we provide a comprehensive review of the mechanisms and optimization of MSC therapy in ARDS and highlighted the potentials and possible barriers of MSC therapy for COVID-19 patients with ARDS.
    Mesh-Begriff(e) Adoptive Transfer ; Alveolar Epithelial Cells/pathology ; Animals ; Apoptosis ; Betacoronavirus ; Body Fluids/metabolism ; CD4-Positive T-Lymphocytes/immunology ; COVID-19 ; Clinical Trials as Topic ; Coinfection/prevention & control ; Coinfection/therapy ; Coronavirus Infections/complications ; Coronavirus Infections/immunology ; Disease Models, Animal ; Endothelial Cells/pathology ; Extracorporeal Membrane Oxygenation ; Genetic Therapy/methods ; Genetic Vectors/administration & dosage ; Genetic Vectors/therapeutic use ; Humans ; Immunity, Innate ; Inflammation Mediators/metabolism ; Lung/pathology ; Lung/physiopathology ; Mesenchymal Stem Cell Transplantation/methods ; Mesenchymal Stem Cells/physiology ; Multiple Organ Failure/etiology ; Multiple Organ Failure/prevention & control ; Pandemics ; Pneumonia, Viral/complications ; Pneumonia, Viral/immunology ; Respiratory Distress Syndrome/immunology ; Respiratory Distress Syndrome/pathology ; Respiratory Distress Syndrome/therapy ; SARS-CoV-2 ; Translational Research, Biomedical
    Chemische Substanzen Inflammation Mediators
    Schlagwörter covid19
    Sprache Englisch
    Erscheinungsdatum 2020-06-09
    Erscheinungsland Germany
    Dokumenttyp Journal Article ; Review
    ZDB-ID 2543451-2
    ISSN 1674-8018 ; 1674-8018
    ISSN (online) 1674-8018
    ISSN 1674-8018
    DOI 10.1007/s13238-020-00738-2
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  3. Artikel ; Online: Long noncoding RNA LBX2-AS1 promotes colorectal cancer progression via binding with PTBP1 and stabilizing KAT2A expression.

    Zhao, Andong / Wang, Yu / Lin, Fuliang / Bai, Keyun / Gu, Chao

    Journal of biochemical and molecular toxicology

    2022  Band 36, Heft 5, Seite(n) e23020

    Abstract: The long noncoding RNAs (lncRNAs) have been investigated in colorectal cancer (CRC). The aim of this study is to identify the biological functions of LBX2-AS1 in CRC. Quantitative real-time polymerase chain reaction was used to examine the expression of ... ...

    Abstract The long noncoding RNAs (lncRNAs) have been investigated in colorectal cancer (CRC). The aim of this study is to identify the biological functions of LBX2-AS1 in CRC. Quantitative real-time polymerase chain reaction was used to examine the expression of LBX2-AS1 in CRC cells. Cell counting kit-8 and colony formation assays were performed to examine cell proliferation. Wound healing and transwell invasion assays were performed to examine the cell migration and invasion. The interaction between PTBP1 and LBX2-AS1 or KAT2A was confirmed by RNA immunoprecipitation. The KAT2A messenger RNA (mRNA) stability was probed using the transcriptional inhibitor Actinomycin D. LBX2-AS1 was significantly increased in CRC tissues and cells. Knockdown of LBX2-AS1 inhibited CRC cell proliferation, migration, and invasion. The notch signaling pathway was activated by LBX2-AS1. LBX2-AS1 enhanced the mRNA stability of the histone acetyltransferase KAT2A by interacting with RNA-binding protein PTBP1. LBX2-AS1 acted as an oncogene in CRC.
    Mesh-Begriff(e) Cell Line, Tumor ; Cell Movement ; Cell Proliferation ; Colorectal Neoplasms/genetics ; Colorectal Neoplasms/metabolism ; Gene Expression Regulation, Neoplastic ; Heterogeneous-Nuclear Ribonucleoproteins/genetics ; Heterogeneous-Nuclear Ribonucleoproteins/metabolism ; Histone Acetyltransferases/biosynthesis ; Histone Acetyltransferases/genetics ; Histone Acetyltransferases/metabolism ; Humans ; MicroRNAs/metabolism ; Polypyrimidine Tract-Binding Protein/genetics ; Polypyrimidine Tract-Binding Protein/metabolism ; RNA, Long Noncoding/genetics ; RNA, Long Noncoding/metabolism
    Chemische Substanzen Heterogeneous-Nuclear Ribonucleoproteins ; MicroRNAs ; PTBP1 protein, human ; RNA, Long Noncoding ; Polypyrimidine Tract-Binding Protein (139076-35-0) ; Histone Acetyltransferases (EC 2.3.1.48) ; KAT2A protein, human (EC 2.3.1.48)
    Sprache Englisch
    Erscheinungsdatum 2022-03-07
    Erscheinungsland United States
    Dokumenttyp Journal Article
    ZDB-ID 1410020-4
    ISSN 1099-0461 ; 1095-6670
    ISSN (online) 1099-0461
    ISSN 1095-6670
    DOI 10.1002/jbt.23020
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  4. Artikel ; Online: Substance basis and pharmacological mechanism of heat-clearing herbs in the treatment of ischaemic encephalopathy: a systematic review and network pharmacology.

    Zhao, Andong / Sun, Qianqian / Zhang, Jiahao / Hu, Tian / Zhou, Xuewei / Wang, Chuan / Liu, Jiping / Wang, Bin

    Annals of medicine

    2024  Band 56, Heft 1, Seite(n) 2308077

    Abstract: Background and objective: Ischaemic encephalopathy is a common cerebrovascular disease caused by insufficient blood supply to the cerebral vessels. The ischaemic encephalopathy is closely associated with the development of many chronic diseases such as ... ...

    Abstract Background and objective: Ischaemic encephalopathy is a common cerebrovascular disease caused by insufficient blood supply to the cerebral vessels. The ischaemic encephalopathy is closely associated with the development of many chronic diseases such as obesity, hypertension and diabetes. Neurotrophic therapy has become the main therapeutic strategy for ischaemic encephalopathy. However, neurotrophic drugs only slightly recover the neurological function of patients, and their long-term efficacy is uncertain. Previous reports revealed that the active ingredients of natural medicines play important roles in the treatment of cerebral ischemia. In this study, we reviewed clearing herbs with anti-ischaemic encephalopathy functions using the data from quantitative statistical and network pharmacological exploration methods. We also discussed the different bioactive components and pharmacological effects of these herbs.
    Methods: First, we collected Chinese herbal prescriptions against ischaemic encephalopathy in four databases. Then, we statistically analysed the frequency of application of heat-clearing herbs to obtain the commonly used heat-clearing herbs against ischaemic encephalopathy, and classified them according to their efficacy according to the statistical results, to summarize the mechanism of anti-ischaemic effects of different bioactive components; Second, the network database was used to obtain the above components of heat-clearing Chinese medicines and their corresponding targets of action, disease targets of ischaemic stroke; Venny 2.1.0 was used to obtain component-disease target intersections; Cytoscape was used to construct the 'Drug-Active Ingredient-Target Network Graph '; DAVID was used for GO and KEGG enrichment analysis.
    Results: Literature and database screening involved 149 prescriptions, with a total of 269 flavours of Chinese medicines and 20 flavours of single-flavour heat-clearing Chinese medicines; The top nine in terms of frequency of use were Radix Paeoniae Rubra、Rehmanniae Radix Praeparata、Figwort Root、Cortex Moutan、Scutellariae Radix、Coptidis Rhizoma、Gardeniae Fructus、Cassiae Semen、Lonicerae Japonicae Flos. The common components obtained from network pharmacology were beta-sitosterol, quercetin, and stigmasterol, which mainly act on key targets such as RELA, AKT1, JUN, PRKACA, PTGS2, RAF1 and CHUK; and their active ingredients are mainly involved in signalling pathways such as Calcium, PI3K-Ak, MAPK, cAMP, IL-17, HIF-1, TNF, T-cell receptor, NF-kappa B and JAK-STAT.
    Conclusions: Heat-clearing herbs are useful and promising for the protection against and prevention of ischemic encephalopathy. The results of the network pharmacological studies are similar to the mechanisms of anti-ischemic encephalopathy of the active ingredients of the purgative herbs we have listed; Thin either directly protects cerebrovascular tissues by improving vascular permeability and reducing the area of infarcted tissues, or produces protective effects through molecular signaling pathways. It can be seen that the components of heat-clearing Chinese medicines can exert cerebroprotective effects through multiple pathways, which provides us with a reference for further development and study of heat-clearing Chinese medicines in the treatment of ischemic cerebrovascular diseases.
    Mesh-Begriff(e) Humans ; Brain Ischemia/drug therapy ; Hot Temperature ; Network Pharmacology ; Stroke ; Ischemic Stroke
    Sprache Englisch
    Erscheinungsdatum 2024-01-29
    Erscheinungsland England
    Dokumenttyp Systematic Review ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1004226-x
    ISSN 1365-2060 ; 1651-2219 ; 0785-3890 ; 1743-1387
    ISSN (online) 1365-2060 ; 1651-2219
    ISSN 0785-3890 ; 1743-1387
    DOI 10.1080/07853890.2024.2308077
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  5. Artikel: Numerical modelling of storm surge, nutrient pollution and saltwater intrusion in a large estuary with typhoon effects

    Zhang, Hong-xing / Shen, Yong-ming / Zhao, An-dong / Tang, Jun

    Environmental modelling & software. 2022 June 15,

    2022  

    Abstract: A coupled modelling framework, consisting of the storm surge model and the European Regional Seas Ecosystem Model (ERSEM), has been established to examine hydrodynamics process during Typhoon Hagupit and its role on nutrient and salinity dynamics in the ... ...

    Abstract A coupled modelling framework, consisting of the storm surge model and the European Regional Seas Ecosystem Model (ERSEM), has been established to examine hydrodynamics process during Typhoon Hagupit and its role on nutrient and salinity dynamics in the Pearl River Estuary (PRE). The accuracy of modelling framework was reasonably validated against measured typhoon wind, storm tide, and water quality data. Further analysis suggests Hagupit significantly increases water levels in the PRE. Meanwhile, the seaward residual currents apparently and chaotically change. The phosphate and dissolved inorganic nitrogen concentrations decrease by 0.2–1.8 and 20–88.6 μmol/L in the most area from the downstream of narrow river channels to offshore region due to the variations of hydrodynamics, while small difference was detected in upstream narrow channels and open sea. By contrast, salinity distribution showed opposite variation. Statistically, the typhoon winds alleviated the averaged nutrient pollution in the whole PRE, while causing serious saltwater intrusion.
    Schlagwörter computer software ; ecological models ; estuaries ; hydrodynamics ; nitrogen ; phosphates ; pollution ; rivers ; salinity ; saltwater intrusion ; typhoons ; water quality ; wind
    Sprache Englisch
    Erscheinungsverlauf 2022-0615
    Erscheinungsort Elsevier Ltd
    Dokumenttyp Artikel
    Anmerkung Pre-press version
    ISSN 1364-8152
    DOI 10.1016/j.envsoft.2022.105449
    Datenquelle NAL Katalog (AGRICOLA)

    Zusatzmaterialien

    Kategorien

  6. Artikel ; Online: Mesenchymal stem cell therapy for acute respiratory distress syndrome

    Qin, Hua / Zhao, Andong

    Protein & Cell

    from basic to clinics

    2020  Band 11, Heft 10, Seite(n) 707–722

    Abstract: Abstract The 2019 novel coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has occurred in China and around the world. SARS-CoV-2-infected patients with severe pneumonia rapidly develop acute ... ...

    Abstract Abstract The 2019 novel coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has occurred in China and around the world. SARS-CoV-2-infected patients with severe pneumonia rapidly develop acute respiratory distress syndrome (ARDS) and die of multiple organ failure. Despite advances in supportive care approaches, ARDS is still associated with high mortality and morbidity. Mesenchymal stem cell (MSC)-based therapy may be an potential alternative strategy for treating ARDS by targeting the various pathophysiological events of ARDS. By releasing a variety of paracrine factors and extracellular vesicles, MSC can exert anti-inflammatory, anti-apoptotic, anti-microbial, and pro-angiogenic effects, promote bacterial and alveolar fluid clearance, disrupt the pulmonary endothelial and epithelial cell damage, eventually avoiding the lung and distal organ injuries to rescue patients with ARDS. An increasing number of experimental animal studies and early clinical studies verify the safety and efficacy of MSC therapy in ARDS. Since low cell engraftment and survival in lung limit MSC therapeutic potentials, several strategies have been developed to enhance their engraftment in the lung and their intrinsic, therapeutic properties. Here, we provide a comprehensive review of the mechanisms and optimization of MSC therapy in ARDS and highlighted the potentials and possible barriers of MSC therapy for COVID-19 patients with ARDS.
    Schlagwörter Biotechnology ; Cell Biology ; Biochemistry ; Drug Discovery ; covid19
    Sprache Englisch
    Verlag Springer Science and Business Media LLC
    Erscheinungsland us
    Dokumenttyp Artikel ; Online
    ZDB-ID 2543451-2
    ISSN 1674-8018 ; 1674-800X
    ISSN (online) 1674-8018
    ISSN 1674-800X
    DOI 10.1007/s13238-020-00738-2
    Datenquelle BASE - Bielefeld Academic Search Engine (Lebenswissenschaftliche Auswahl)

    Zusatzmaterialien

    Kategorien

  7. Artikel: Mesenchymal stem cell therapy for acute respiratory distress syndrome: from basic to clinics

    Qin, Hua / Zhao, Andong

    Protein Cell

    Abstract: The 2019 novel coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has occurred in China and around the world. SARS-CoV-2-infected patients with severe pneumonia rapidly develop acute respiratory ... ...

    Abstract The 2019 novel coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has occurred in China and around the world. SARS-CoV-2-infected patients with severe pneumonia rapidly develop acute respiratory distress syndrome (ARDS) and die of multiple organ failure. Despite advances in supportive care approaches, ARDS is still associated with high mortality and morbidity. Mesenchymal stem cell (MSC)-based therapy may be an potential alternative strategy for treating ARDS by targeting the various pathophysiological events of ARDS. By releasing a variety of paracrine factors and extracellular vesicles, MSC can exert anti-inflammatory, anti-apoptotic, anti-microbial, and pro-angiogenic effects, promote bacterial and alveolar fluid clearance, disrupt the pulmonary endothelial and epithelial cell damage, eventually avoiding the lung and distal organ injuries to rescue patients with ARDS. An increasing number of experimental animal studies and early clinical studies verify the safety and efficacy of MSC therapy in ARDS. Since low cell engraftment and survival in lung limit MSC therapeutic potentials, several strategies have been developed to enhance their engraftment in the lung and their intrinsic, therapeutic properties. Here, we provide a comprehensive review of the mechanisms and optimization of MSC therapy in ARDS and highlighted the potentials and possible barriers of MSC therapy for COVID-19 patients with ARDS.
    Schlagwörter covid19
    Verlag WHO
    Dokumenttyp Artikel
    Anmerkung WHO #Covidence: #626150
    Datenquelle COVID19

    Kategorien

  8. Artikel ; Online: Patient-Specific Cells for Modeling and Decoding Amyotrophic Lateral Sclerosis: Advances and Challenges.

    Zhao, Andong / Pan, Yu / Cai, Sa

    Stem cell reviews and reports

    2020  Band 16, Heft 3, Seite(n) 482–502

    Abstract: Motor neuron loss or degeneration is the typical characteristic of amyotrophic lateral sclerosis (ALS), which often leads to weakness, paralysis, or even death. The underlying mechanisms of motor neuron degeneration and ALS progression remain elusive, ... ...

    Abstract Motor neuron loss or degeneration is the typical characteristic of amyotrophic lateral sclerosis (ALS), which often leads to weakness, paralysis, or even death. The underlying mechanisms of motor neuron degeneration and ALS progression remain elusive, and there is no effective treatment for ALS. The advances of stem cells and reprogramming techniques has made it possible to generate patient-specific motor neurons as cell models for studying disease mechanisms and drug discovery. This review comprehensively discusses recent approaches to generate motor neurons from stem cells and somatic cells and highlights the application of induced motor neurons to modeling ALS diseases, dissecting the pathogenesis, and screening new drugs. New perspectives are also discussed on generating patient-specific motor neuron subtypes that are affected by ALS or creating 3D spinal cord organoid models for better recapitulating and understanding ALS.
    Mesh-Begriff(e) Amyotrophic Lateral Sclerosis/genetics ; Amyotrophic Lateral Sclerosis/pathology ; Cellular Reprogramming ; Drug Discovery ; Humans ; Models, Biological ; Motor Neurons/pathology ; Mutation/genetics
    Sprache Englisch
    Erscheinungsdatum 2020-01-08
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 2495577-2
    ISSN 2629-3277 ; 1558-6804 ; 1550-8943
    ISSN (online) 2629-3277 ; 1558-6804
    ISSN 1550-8943
    DOI 10.1007/s12015-019-09946-8
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  9. Artikel ; Online: The SDF-1/CXCR4 Signaling Pathway Directs the Migration of Systemically Transplanted Bone Marrow Mesenchymal Stem Cells Towards the Lesion Site in a Rat Model of Spinal Cord Injury.

    Zhao, Andong / Chung, Manhon / Yang, Yi / Pan, Xiaohua / Pan, Yu / Cai, Sa

    Current stem cell research & therapy

    2022  Band 18, Heft 2, Seite(n) 216–230

    Abstract: Background: It has been observed that bone marrow-derived mesenchymal stem cells (MSCs) migrate towards the injured spinal cord and promote functional recovery when systemically transplanted into the traumatized spinal cord. However, the mechanisms ... ...

    Abstract Background: It has been observed that bone marrow-derived mesenchymal stem cells (MSCs) migrate towards the injured spinal cord and promote functional recovery when systemically transplanted into the traumatized spinal cord. However, the mechanisms underlying their migration to the spinal cord remain poorly understood.
    Methods: In this study, we systemically transplanted GFP- and luciferase-expressing MSCs into rat models of spinal cord injury and examined the role of the stromal cell-derived factor 1 (SDF-1)/CXCR4 axis in regulating the migration of transplanted MSCs to the spinal cord. After intravenous injection, MSCs migrated to the injured spinal cord where the expression of SDF-1 was increased. Spinal cord recruitment of MSCs was blocked by pre-incubation with an inhibitor of CXCR4. Their presence correlated with morphological and functional recovery. In vitro, SDF-1 or cerebrospinal fluid (CSF) collected from SCI rats promoted a dose-dependent migration of MSCs in culture, which was blocked by an inhibitor of CXCR4 or SDF-1 antibody.
    Results and conclusion: The study suggests that SDF-1/CXCR4 interactions recruit exogenous MSCs to injured spinal cord tissues and may enhance neural regeneration. Modulation of the homing capacity may be instrumental in harnessing the therapeutic potential of MSCs.
    Mesh-Begriff(e) Rats ; Animals ; Rats, Sprague-Dawley ; Spinal Cord Injuries/therapy ; Spinal Cord Injuries/pathology ; Mesenchymal Stem Cells ; Signal Transduction ; Chemokine CXCL12/metabolism ; Mesenchymal Stem Cell Transplantation/methods ; Cell Movement ; Bone Marrow Cells/metabolism ; Receptors, CXCR4/metabolism
    Chemische Substanzen Chemokine CXCL12 ; Cxcr4 protein, rat ; Receptors, CXCR4
    Sprache Englisch
    Erscheinungsdatum 2022-05-20
    Erscheinungsland United Arab Emirates
    Dokumenttyp Journal Article
    ZDB-ID 2251937-3
    ISSN 2212-3946 ; 1574-888X
    ISSN (online) 2212-3946
    ISSN 1574-888X
    DOI 10.2174/1574888X17666220510163245
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  10. Artikel ; Online: An optimized method to visualize the goblet cell-associated antigen passages and identify goblet cells in the intestine, conjunctiva, and airway.

    Tang, Mao / Mei, Jinyu / Sun, Mengli / Ma, Kui / Zhao, Andong / Fu, Xiaobing

    Immunobiology

    2022  Band 227, Heft 6, Seite(n) 152260

    Abstract: The goblet cell-associated antigen passages (GAPs), formed in the intestine and conjunctiva, contribute to immune responses by delivering antigens to immune cells. It has been proved that dysfunctions of GAPs may contribute to intestinal inflammation and ...

    Abstract The goblet cell-associated antigen passages (GAPs), formed in the intestine and conjunctiva, contribute to immune responses by delivering antigens to immune cells. It has been proved that dysfunctions of GAPs may contribute to intestinal inflammation and dry eye disease. GAPs were first discovered in the intestine with the help of intravital two-photon microscopy. The imaging of GAPs was subsequently captured in a frozen section and whole-mount immunofluorescent staining. Both protocols have their features. This study provides a new protocol for visualizing GAPs with better mucus preservation by combining 4% PFA and methanol-Carnoy's solution (PFA-MC). In addition, embedding samples in paraffin provides an opportunity for antigen retrieval for immunohistochemistry analysis. Using this protocol, we have successfully visualized GAPs in the intestine, intestinal organoids, conjunctiva, and trachea. It is worth mentioning that the visualization of GAPs in intestinal organoids and airways has rarely been discussed before, which may assist researchers in their studies. Moreover, we also discovered the active uptake of dextran of club cells in terminal bronchioles, which may provide a new direction for studying the function of club cells. Overall, we developed a new method to visualize GAP formation and identify GCs simultaneously in the intestine, organoid, conjunctiva, and airway.
    Mesh-Begriff(e) Goblet Cells ; Conjunctiva ; Antigens ; Intestines ; Mucus
    Chemische Substanzen Antigens
    Sprache Englisch
    Erscheinungsdatum 2022-08-17
    Erscheinungsland Netherlands
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 563292-4
    ISSN 1878-3279 ; 0171-2985
    ISSN (online) 1878-3279
    ISSN 0171-2985
    DOI 10.1016/j.imbio.2022.152260
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang